Plexus Capital and 424 Capital Invest in VaLogic Bio
September 19, 2023
Plexus Capital and 424 Capital announced an investment in VaLogic Bio, a Frederick, Maryland-based provider of GMP compliance software and life-sciences laboratory services. The capital will support VaLogic’s continued growth of its facility monitoring SaaS and professional compliance services for FDA-regulated clients.
- Buyers
- Plexus Capital, LLC, 424 Capital
- Targets
- VaLogic Bio
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.